Literature DB >> 28231019

Proinflammatory Cytokines Impair Vitamin D-Induced Host Defense in Cultured Airway Epithelial Cells.

Jasmijn A Schrumpf1, Gimano D Amatngalim1, Joris B Veldkamp1, Renate M Verhoosel1, Dennis K Ninaber1, Soledad R Ordonez2, Anne M van der Does1, Henk P Haagsman2, Pieter S Hiemstra1.   

Abstract

Vitamin D is a regulator of host defense against infections and induces expression of the antimicrobial peptide hCAP18/LL-37. Vitamin D deficiency is associated with chronic inflammatory lung diseases and respiratory infections. However, it is incompletely understood if and how (chronic) airway inflammation affects vitamin D metabolism and action. We hypothesized that long-term exposure of primary bronchial epithelial cells to proinflammatory cytokines alters their vitamin D metabolism, antibacterial activity, and expression of hCAP18/LL-37. To investigate this, primary bronchial epithelial cells were differentiated at the air-liquid interface for 14 days in the presence of the proinflammatory cytokines, TNF-α and IL-1β (TNF-α/IL-1β), and subsequently exposed to vitamin D (inactive 25(OH)D3 and active 1,25(OH)2D3). Expression of hCAP18/LL-37, vitamin D receptor, and enzymes involved in vitamin D metabolism (CYP24A1 and CYP27B1) was determined using quantitative PCR, Western blot, and immunofluorescence staining. Furthermore, vitamin D-mediated antibacterial activity was assessed using nontypeable Haemophilus influenzae. We found that TNF-α/IL-1β treatment reduced vitamin D-induced expression of hCAP18/LL-37 and killing of nontypeable H. influenzae. In addition, CYP24A1 (a vitamin D-degrading enzyme) was increased by TNF-α/IL-1β, whereas CYP27B1 (that converts 25(OH)D3 to its active form) and vitamin D receptor expression remained unaffected. Furthermore, we have demonstrated that the TNF-α/IL-1β-mediated induction of CYP24A1 was, at least in part, mediated by the transcription factor specific protein 1, and the epidermal growth factor receptor-mitogen-activated protein kinase pathway. These findings indicate that TNF-α/IL-1β decreases vitamin D-mediated antibacterial activity and hCAP18/LL-37 expression via induction of CYP24A1 and suggest that chronic inflammation impairs protective responses induced by vitamin D.

Entities:  

Keywords:  airway epithelial cells; hCAP18/LL-37; host defense; proinflammatory mediators; vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28231019     DOI: 10.1165/rcmb.2016-0289OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

1.  Vitamin D in Host Defense: Implications for Future Research.

Authors:  Scott T Weiss; Augusto A Litonjua
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

2.  Novel insights into the effects of cigarette smoke on the airway epithelial surface-lessons learned at the European Respiratory Society International Congress 2018 in Paris.

Authors:  Gimano D Amatngalim; Rodolfo Paula Vieira; Silke Meiners; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  TGF-β1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms.

Authors:  Jasmijn A Schrumpf; Dennis K Ninaber; Anne M van der Does; Pieter S Hiemstra
Journal:  J Innate Immun       Date:  2019-04-10       Impact factor: 7.349

4.  Role of C3a as a Novel Regulator of 25(OH)D3 to 1α,25-Dihydroxyvitamin D3 Metabolism in Upper Airway Epithelial Cells.

Authors:  Jennifer K Mulligan; Dianna Nord; Maria V Villanueva; Jeb Justice; Brian Lobo; Rodney J Schlosser; Carl Atkinson
Journal:  J Immunol       Date:  2022-07-06       Impact factor: 5.426

Review 5.  Calcifediol for Use in Treatment of Respiratory Disease.

Authors:  Marta Entrenas-Castillo; Lourdes Salinero-González; Luis M Entrenas-Costa; Rubén Andújar-Espinosa
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

6.  Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  David A Jolliffe; Christos Stefanidis; Zhican Wang; Nazanin Z Kermani; Vassil Dimitrov; John H White; John E McDonough; Wim Janssens; Paul Pfeffer; Christopher J Griffiths; Andrew Bush; Yike Guo; Stephanie Christenson; Ian M Adcock; Kian Fan Chung; Kenneth E Thummel; Adrian R Martineau
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

7.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

Review 8.  Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.

Authors:  Anne M van der Does; Gimano D Amatngalim; Bart Keijser; Pieter S Hiemstra; Remi Villenave
Journal:  Vaccines (Basel)       Date:  2018-07-28

Review 9.  Vitamin D status and its influence on outcomes following major burn injury and critical illness.

Authors:  Naiem Moiemen; Janet M Lord; Khaled Al-Tarrah; Martin Hewison
Journal:  Burns Trauma       Date:  2018-04-16

Review 10.  Antiviral therapeutic approaches for human rhinovirus infections.

Authors:  Victor Casanova; Filipa H Sousa; Craig Stevens; Peter G Barlow
Journal:  Future Virol       Date:  2018-06-12       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.